Stem cell therapies hold promise as a cure for diseases but not without some risk, since faulty regulation of stem cells leads to a huge range of human diseases. Even before birth, mistakes made by the stem cells are a major cause of congenital defects and cancer can also be caused by the body losing control of stem cell function.
Guiding stem cells along the correct pathways and reversing their mistakes is one target of cancer research and scientists from Tufts University say they have identified a novel and readily modifiable signal by which an organism can control the behavior of stem cell offspring.
Their laboratory works on bioelectrical signaling. There is always a difference in voltage, called the transmembrane potential, between the inside and outside of all cells, and controlling exactly what this difference is turns out to be vitally important. Specialized protein checkpoints sited in a cell's outer membrane regulate ion flow in and out of the cell, producing voltage gradients. These, combined with more conventional protein-based signaling systems, can specify cell destiny.
Building on other work at Tufts, that the properties of human stem cells growing in artificial culture could be drastically altered by changing their transmembrane potential, they asked whether tampering with the transmembrane potential of one kind of cell could have a 'domino effect' in a whole organism, altering the destiny of other cell types.
To do this, they focused on the development of neural crest stem cells, which are responsible for directing development of the face and heart, but which also generate melanocytes, the pigment cells of the skin. Using frog tadpoles and melanocytes as a model system, they showed that tweaking the transmembrane potential of a tiny population of 'instructor' cells sends a signal to developing melanocytes that causes them to overgrow and start to resemble metastatic cancer cells.
Most excitingly, they found that the signal can travel over long distances in the tadpole, and that the messenger carrying it is serotonin – an important neurotransmitter involved in mood regulation and many other aspects of nervous system function.
This novel bioelectrical method of changing stem cell behavior has huge implications. It is very likely that there are similar 'instructor' cells that direct other important cell populations, and changing their voltage gradients would be relatively easy (Levin's lab simply used an anti-parasitic drug already available on prescription).
The resulting bioelectrical therapy could potentially be harnessed to improve regenerative repair after injury, repair birth defects and detect and prevent cancer.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Suggestion: The EM Drive Is Getting The Appropriate Level Of Attention From The Science Community
- Junk Science Report Card
- Animal Sex Is Spicier Than We Thought
- Will Aspartame Critics Now Be Less Bitter?
- Review Claims Link Between Wireless Devices And Cancer
- The Heat Is Still On Dr. Oz
- Your Fear Of Radiation Is Irrational
- "Your headline is unscientific and your talking points are old, I feel like I've read this piece..."
- "I guess it's time to plan some farewell glacier tour hikes. The ones in Glacier National Park and..."
- "So how much poison did you ingest sitting at your PC copying and pasting all of that stuff? You..."
- "Wow, you just waste my 20 minutes with your conditioned mind full of shitty concepts..Well played..."
- "Herman J. Muller, 1927 paper, radiation causes genetic mutations, these mistakes will cause extinction..."
- Excessive or inadequate? Confusion about medication is common
- Breast cancer in young women is rarer than media make it seem
- GE crops could save the planet, if Organic advocates let them
- No excuses to be against science now: Monsanto patent expires
- The Pendulum Swings: Prescribing Hormone Replacement Therapy 13 Years After the Women’s Health Initiative Study
- The search for new blood donors ends at the living – but why?